Form 4: InfuSystem Executive Receives Equity Compensation

InfuSystem Holdings, Inc. Executive VP and CIO Addam Chupa was granted stock options and restricted stock units as part of an equity compensation package.

Summary

• Addam Chupa, Executive VP and CIO of InfuSystem Holdings, Inc., received a grant of 20,777 stock options and 9,973 restricted stock units (RSUs) on May 12, 2026.
• The stock options have an exercise price of $8.37 and vest in four equal annual installments starting May 12, 2027.
• The RSUs vest in three equal annual installments starting May 12, 2027.
• The reporting person's total beneficial ownership includes 47,210 shares, which accounts for 2,254 shares recently acquired via the Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of executive interests with long-term shareholder value through multi-year vesting schedules.
• Increased employee participation in the company's equity through the Employee Stock Purchase Plan.

Negatives

• Potential for future shareholder dilution upon the exercise of options and vesting of RSUs.

Risks

• Market price volatility affecting the value of granted equity incentives.
• Retention risk if performance targets or vesting conditions are not met.

Future Outlook

The equity grants are subject to multi-year vesting schedules, indicating a long-term retention strategy for the executive.

Industry Context

StockSavvy.ai notes that equity-based compensation for C-suite executives is standard practice in the healthcare technology sector to ensure leadership alignment with long-term corporate performance and shareholder interests.

Comparison to Industry Standards

• The use of multi-year vesting schedules (3-4 years) is consistent with standard corporate governance practices for executive compensation in the U.S. healthcare sector.
• The inclusion of both options and RSUs is a common hybrid approach to balance risk and retention.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual exercise of these equity instruments.

Next Steps

• Vesting of initial tranches of stock options and RSUs on May 12, 2027.

Key Dates

Keywords

InfuSystem, INFU, Form 4, Executive Compensation, Stock Options, Restricted Stock Units, Insider Transaction